🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo MDI HFA

Found 58 matching trials

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

PHASE3

The purpose of this study is to compare the efficacy and safety of the fixe...

Status

Completed

Location

Research Center

Start Date

2006-06

Trial ID

NCT00393952

Treatments Being Tested

Fluticasone propionate/Formoterol fumarate 250/10 Placebo Fluticasone propionate/Formoterol fumarate 100/10 Fluticasone propionate 250 Formoterol fumarate 10

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

PHASE3

This is a Phase 3, randomized, placebo-controlled, double-blind,double-dumm...

Status

Completed

Location

Teva Investigational Site 10851

Start Date

2013-12

Trial ID

NCT02031640

Treatments Being Tested

Beclomethasone dipropionate Placebo Albuterol/salbutamol

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

PHASE3

This is a multi-center, randomized, double-blinded, placebo-controlled, cro...

Status

Completed

Location

West Coast Clinical Trials Global

Start Date

2012-10

Trial ID

NCT01737905

Treatments Being Tested

Epinephrine HFA-MDI (E004)Placebo-HFA

A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

PHASE2

This study is examining how well a dry powder inhaler (DPI) of albuterol me...

Status

Completed

Location

Teva Clinical Study Site

Start Date

2010-02

Trial ID

NCT01058863

Treatments Being Tested

Albuterol Spiromax®ProAir® HFA Placebo Inhaler

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

PHASE3

The primary objective of this study is to compare the QVAR-Easi-Breathe 100...

Status

Completed

Location

Allergy and Asthma Specialists

Start Date

2004-10-31

Trial ID

NCT00094016

Treatments Being Tested

beclomethasone dipropionate

Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd

PHASE3

This is a pharmacodynamic bioequivalence bronchoprovocation study using sin...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2024-10-15

Trial ID

NCT06618105

Treatments Being Tested

Albuterol Sulfate 90 MCG/INHAL Metered Dose Inhaler, 200 Actuations Test Placebo Reference Placebo Albuterol Sulfate 90 MCG/INHAL Metered Dose Inhaler, 200 Actuations

Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma

PHASE2

This is a randomized, double-blind, single-dose, placebo-controlled, 5-peri...

Status

Completed

Location

Research Site

Start Date

2017-12-15

Trial ID

NCT03364608

Treatments Being Tested

AS MDI 90 μg AS MDI 180 µg Placebo MDI Proventil 90 μg Proventil 180 μg

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

PHASE2

The aim of this exploratory investigation is to evaluate if the Forced Expi...

Status

Completed

Location

Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Street Medical Centre

Start Date

2008-02

Trial ID

NCT01343745

Treatments Being Tested

BDP/formoterol BDP/formoterol Placebo

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

PHASE3

The aim of this trial is to evaluate the efficacy and safety of 2.5 and 5 m...

Status

Completed

Location

205.419.01058 Boehringer Ingelheim Investigational Site

Start Date

2010-08

Trial ID

NCT01172821

Treatments Being Tested

placebo placebo placebo tiotropium Respimat® low dose placebo tiotropium Respimat® high dose 50 mcg salmeterol HFA MDI placebo

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

PHASE1

The study is being conducted to compare the pharmacokinetic (PK) of BDP (an...

Status

Completed

Location

SGS Belgium NV - Clinical Pharmacology Unit

Start Date

2023-04-24

Trial ID

NCT05898984

Treatments Being Tested

Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI Reference product 1 (R1): CHF 5993 BDP/FF/GB 100/6/12.5 µg pMDI Reference product 2 (R2): BDP HFA (QVAR REDIHALER®, BDP 80 μg)

Previous Next